Clinical Trials for Asher Biotherapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Asher Biotherapeutics

Clinical Trials (3)

NCT07037758
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
PHASE1Recruiting
380 participants
Started: Sep 16, 2025 · Completed: Jan 4, 2031
1 condition2 sponsors4 locations
NCT07027488
AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
50 participants
Started: Aug 5, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT05653882
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
PHASE1Active, not recruiting
552 participants
Started: Jan 4, 2023 · Completed: May 31, 2027
5 conditions2 sponsors20 locations